State Street Corporation has appointed healthcare product producer Covidien chairman José (Joe) E. Almeida to its board of directors.
With more than 18 years leadership experience at the large public company, Almeida will bring a valuable knowledge of innovation and competition to the financial services research group, Joseph L. Hooley, chairman, president and chief executive officer of State Street Corporation, said.
Almeida joined Covidien in 1995 and has served as chairman of the company's board of directors since March 2012.
He has also previously held senior roles at Greatbatch Technologies, Inc., American Home Products' Acufex Microsurgical division and Johnson & Johnson's professional products division.
Almeida is also on the board of directors at Advanced Medical Technology Association (AdvaMed) and Partners in Health.
The $16 billion fund has teamed up with a retirement income product specialist to give its members more confidence to spend in retirement.
The super fund-owned institutional investment manager has appointed an internal candidate as its next head of operations.
The $91 billion fund has doubled down on its data security, alongside enhancing its investment strategy, with two key appointments.
The Albanese government has appointed Jim Craig as a member of the Future Fund Board of Guardians for a five‑year term.